In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach
Brett Fleisher(University of Florida), Sihem Ait‐Oudhia(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 11
Related Papers
No related papers found
Powered by citation graph analysis